Check out our most popular compounded medications! Get Started
Brompheniramine Maleate 8 mg Slow Release Capsules, formulated with Methocel E4M, are designed to gradually release the active ingredient over an extended period. This controlled-release mechanism offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance. The capsules are used to treat conditions such as Allergic Rhinitis, Urticaria, Pruritus, Asthma, and Chronic Idiopathic Urticaria, providing extended symptom relief.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Brompheniramine Maleate 8 mg Slow Release Capsules are a specialized prescription medication primarily used to alleviate symptoms associated with allergies, colds, and hay fever. This unique formulation is engineered with Methocel E4M, a controlled-release polymer, which ensures a gradual and sustained release of the active ingredient, brompheniramine maleate, over an extended period of time. This slow-release mechanism enhances the therapeutic effects of the medication, reduces the need for frequent dosing, and improves patient compliance, particularly for those requiring a controlled and prolonged release profile.
Brompheniramine maleate is a potent antihistamine that functions by inhibiting the action of histamine, a chemical that the body releases during an allergic reaction. By blocking histamine, brompheniramine maleate effectively mitigates allergy symptoms such as sneezing, itching, and watery eyes. Beyond allergies, this versatile medication can also be utilized to manage symptoms of colds and hay fever, among other conditions.
At Bayview Pharmacy, we take pride in offering this advanced formulation of brompheniramine maleate 8 mg slow release capsules. This formulation is meticulously designed to provide long-lasting relief from symptoms. We are committed to providing high-quality, patient-centered care and are always available to answer any questions or concerns you may have regarding this formulation.
Brompheniramine Maleate 8 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
These capsules may interact with other medications, including those used to treat asthma, allergies, colds, and flu. It is crucial for patients to inform their healthcare provider of all medications they are currently taking, including over-the-counter medications, vitamins, and herbal supplements. Additionally, patients should disclose any existing medical conditions, such as liver or kidney disease, glaucoma, or an enlarged prostate.
Patients are advised not to consume alcohol while taking Brompheniramine Maleate 8 mg Slow Release Capsules, as this may increase the risk of side effects. It is also recommended to avoid taking these capsules with other medications that can cause drowsiness, such as sedatives, muscle relaxants, and antihistamines.
Pregnant or breastfeeding women should not take Brompheniramine Maleate 8 mg Slow Release Capsules, as it may cause harm to the fetus or infant. Patients with a history of heart disease, high blood pressure, or an overactive thyroid should also refrain from taking these capsules.
If you have any questions about the interactions of Brompheniramine Maleate 8 mg Slow Release Capsules with other medications or disease states, please consult with your healthcare provider.
Brompheniramine Maleate 8 mg Slow Release Capsules are a potent medication designed to alleviate symptoms associated with allergies, hay fever, and the common cold. The active ingredient, Brompheniramine Maleate, functions by inhibiting the action of histamine, a substance in the body that triggers allergic symptoms. These capsules are formulated with Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the medication over an extended period. This slow-release mechanism provides a sustained therapeutic effect, reduces the frequency of dosing, and enhances patient compliance, particularly for medications requiring a controlled and prolonged release profile.
They can also be used to manage hives, itching, and other skin reactions. However, it is crucial to note that this medication is not suitable for treating asthma, as it may exacerbate the symptoms.
When using Brompheniramine Maleate 8 mg Slow Release Capsules, it is essential to adhere to the instructions on the package and follow the dosage prescribed by your healthcare provider. The capsules should be consumed with food or milk to minimize the risk of stomach discomfort. Consistency in the timing of medication intake is vital to ensure the steady release of the medication, thereby maintaining its therapeutic effect.
If you have any queries or require further information about Brompheniramine Maleate 8 mg Slow Release Capsules, do not hesitate to reach out. We are committed to helping you understand the workings of this medication and how it can assist you in managing your allergy and cold symptoms effectively.
Brompheniramine Maleate 8 mg Slow Release Capsules are meticulously formulated with Methocel E4M, a specialized controlled-release polymer. This innovative design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism reduces the need for frequent dosing and enhances patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
These capsules are versatile in their application, offering relief from a variety of conditions. They can be used to alleviate symptoms associated with allergic conjunctivitis, reactions to insect bites, and food allergies.
Brompheniramine Maleate 8 mg Slow Release Capsules can also be utilized to treat motion sickness, nausea, and vomiting. They offer relief from hives, itching, and other skin reactions. These capsules provide a comprehensive solution for a range of conditions, offering sustained relief and improved patient compliance.
Brompheniramine Maleate 8 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the active ingredient over an extended period of time.
Methocel E4M is a type of controlled-release polymer. It is used in the formulation to ensure that the medication is released gradually over a prolonged period, offering sustained therapeutic effects.
A slow release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications that require a controlled and prolonged release profile.
Due to the slow release formulation, the frequency of dosing is reduced. However, the exact dosing schedule should be determined by your healthcare provider based on your specific condition and response to therapy.
'Improved patient compliance' means that patients are more likely to take the medication as prescribed. This is because the slow release formulation reduces the frequency of dosing, making it more convenient for patients.
No, the slow release formulation does not affect the effectiveness of the medication. In fact, it enhances the therapeutic effects by ensuring a steady release of the medication over an extended period of time.
No, the capsules should not be broken or chewed. Doing so can interfere with the controlled-release mechanism and may cause the entire dose to be released at once, which could lead to adverse effects.
If you miss a dose, take it as soon as you remember. However, if it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Brompheniramine Maleate 8 mg Slow Release Capsules should only be taken under the supervision of a healthcare provider. It may not be suitable for everyone, and its use should be based on a healthcare provider's assessment of your specific condition and response to therapy.
As with any medication, Brompheniramine Maleate 8 mg Slow Release Capsules can cause side effects. If you experience any unusual symptoms while taking this medication, contact your healthcare provider immediately.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
